CTXR- Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc. (CTXR) has 2 insiders with recent SEC Form 4 filings, including 9 buys and 0 sells. CTXR is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 0 | - | - | |
| Other | 0 | - | - |
Activity
Buys and sells only
Transactions
9 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 27, 2019 | Mazur Leonard L | Executive Chairman | Buy | 2,234,700 | $0.90 | $2,000,279.97 | +27.9% | |
| Sep 27, 2019 | Holubiak Myron Z | President And CEO | Buy | 558,597 | $0.90 | $500,000.17 | +39.0% | |
| Apr 3, 2019 | Mazur Leonard L | Executive Chairman | Buy | 1,165,048 | $1.55 | $1,799,999.16 | +17.0% | |
| Apr 3, 2019 | Holubiak Myron Z | President And CEO | Buy | 129,450 | $1.55 | $200,000.25 | +9.9% | |
| Aug 13, 2018 | Mazur Leonard L | Executive Chairman | Buy | 3,137,255 | $1.28 | $4,000,000.12 | +84.4% | |
| Aug 13, 2018 | Holubiak Myron Z | President And CEO | Buy | 784,314 | $1.28 | $1,000,000.35 | +150.9% | |
| Mar 29, 2018 | Mazur Leonard L | Executive Chairman | Buy | 167,504 | $2.99 | $499,999.44 | +4.7% | |
| Mar 28, 2018 | Holubiak Myron Z | President And CEO | Buy | 2,915 | $3.09 | $9,007.35 | +0.6% | |
| Dec 19, 2017 | Mazur Leonard L | Executive Chairman | Buy | 213,106 | $4.69 | $999,467.14 | +6.4% |